Literature DB >> 17116518

Avoiding "truth": tobacco industry promotion of life skills training.

Lev L Mandel1, Stella Aguinaga Bialous, Stanton A Glantz.   

Abstract

PURPOSE: To understand why and how two tobacco companies have been promoting the Life Skills Training program (LST), a school-based drug prevention program recommended by the Centers for Disease Control and Prevention to reduce youth smoking.
METHODS: We analyzed internal tobacco industry documents available online as of October 2005. Initial searches were conducted using the keywords "life skills training," "LST," and "positive youth development."
RESULTS: Tobacco industry documents reveal that since 1999, Philip Morris (PM) and Brown and Williamson (B&W) have worked to promote LST and to disseminate the LST program into schools across the country. As part of their effort, the companies hired a public relations firm to promote LST and a separate firm to evaluate the program. The evaluation conducted for the two companies did not show that LST was effective at reducing smoking after the first or second year of implementing the program. Even so, the tobacco companies continued to award grants to schools for the program. PM and B&W's role in promoting LST is part of a public relations strategy to shift the "youth smoking paradigm" away from programs that highlight the tobacco industry's behavior and toward programs in which the industry can be a partner.
CONCLUSIONS: Individuals and organizations responsible for developing and implementing tobacco control and youth smoking prevention programs should be aware of PM and B&W's role and motivations to encourage the wide-spread adoption of LST in schools.

Entities:  

Mesh:

Year:  2006        PMID: 17116518     DOI: 10.1016/j.jadohealth.2006.06.010

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  26 in total

1.  Through tobacco industry eyes: civil society and the FCTC process from Philip Morris and British American Tobacco's perspectives.

Authors:  Mariaelena Gonzalez; Lawrence W Green; Stanton A Glantz
Journal:  Tob Control       Date:  2011-06-02       Impact factor: 7.552

2.  "What Is Our Story?" Philip Morris's Changing Corporate Narrative.

Authors:  Patricia A McDaniel; Ruth E Malone
Journal:  Am J Public Health       Date:  2015-08-13       Impact factor: 9.308

3.  Changing service systems for high-risk youth using state-level strategies.

Authors:  Dennis M Gorman
Journal:  Am J Public Health       Date:  2007-04       Impact factor: 9.308

Review 4.  The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries.

Authors:  Sungkyu Lee; Pamela M Ling; Stanton A Glantz
Journal:  Cancer Causes Control       Date:  2012-02-28       Impact factor: 2.506

5.  When tobacco targets direct democracy.

Authors:  Elizabeth Laposata; Allison P Kennedy; Stanton A Glantz
Journal:  J Health Polit Policy Law       Date:  2014-03-06       Impact factor: 2.265

Review 6.  Tobacco industry denormalisation as a tobacco control intervention: a review.

Authors:  Ruth E Malone; Quinn Grundy; Lisa A Bero
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

7.  Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies.

Authors:  Eric Crosbie; Stella Bialous; Stanton A Glantz
Journal:  Tob Control       Date:  2019-01-18       Impact factor: 7.552

8.  Tobacco industry attempts to counter the World Bank report Curbing the Epidemic and obstruct the WHO framework convention on tobacco control.

Authors:  Hadii M Mamudu; Ross Hammond; Stanton Glantz
Journal:  Soc Sci Med       Date:  2008-10-22       Impact factor: 4.634

9.  Targeting high-risk neighborhoods for tobacco prevention education in schools.

Authors:  Christine Elizabeth Kaestle; Bradford B Wiles
Journal:  Am J Public Health       Date:  2009-12-17       Impact factor: 9.308

10.  The role of corporate credibility in legitimizing disease promotion.

Authors:  Patricia A McDaniel; Ruth E Malone
Journal:  Am J Public Health       Date:  2008-12-23       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.